Showing 1041-1050 of 1655 results for "".
- Results of Phase 2 Study Demonstrate Safety and Efficacy of Galderma's Proprietary Liquid Toxinhttps://modernaesthetics.com/news/results-of-phase-2-study-demonstrate-safety-and-efficacy-of-galdermas-proprietary-liquid/2472827/Results of a Phase 2 study show Galderma’s novel liquid abotulinum toxin, QM1114, is safe and effective for the treatment of glabellar lines. Galderma is now poised to advance to Phase 3 testing of the liquid formulation of botulinum toxin type A for the treatment of glabellar lines. The tr
- FDA Approves Juvéderm Voluma XC For Mid-Face Injection Via Cannulahttps://modernaesthetics.com/news/fda-approves-juvderm-voluma-xc-for-mid-face-injection-via-cannula/2471976/Allergan’s Juvéderm Voluma XC is now U.S. Food and Drug Administration (FDA)-approved for cheek augmentation in the mid-face in adults over 21 with a TSK Steriglide cannula. This cannula features a patented tip design with a near-tip delivery port for precise product p
- Social Media Use Linked to Self Esteem, Plastic Surgery Acceptancehttps://modernaesthetics.com/news/social-media-use-linked-to-self-esteem-plastic-surgery-acceptance/2471885/‘Low-selfie’ esteem may be a gateway to cosmetic surgery acceptance, a new study in JAMA Facial Plastic Surgery suggests. Researchers from Johns Hopkins in
- Viper Equity Partners Moves Plastic Surgery Into Consolidation Mainstream with Another Marquis Dealhttps://modernaesthetics.com/news/viper-equity-partners-moves-plastic-surgery-into-consolidation-mainstream-with-another-marquis-deal/2471886/Plastic Surgery is moving into the consolidation Mainstream with another marquis deal by Viper Equity Partners of Palm Beach, FL. Viper was instrumental in a Marquis deal merging their client Aqua Plastic Surgery with Water's Edge Derma
- Drew Barrymore Named First Emsculpt Celebrity Ambassadorhttps://modernaesthetics.com/news/drew-barrymore-named-first-emsculpt-celebrity-ambassador/2471900/Drew Barrymore is Emsculpt's first celebrity ambassador. Through her partnership with Emsculpt, the actress and lifestyle mogul will share her treatment experience and results with media and on her social media channels. Barrym
- It's National Emsculpt Weekhttps://modernaesthetics.com/news/its-national-emsculpt-week/2471907/BTL has proclaimed the week of May 20 "National Emsculpt Week," in honor of the first and only non-invasive treatment to go beyond the elimination of fat cells to strengthen and define muscles. National Emsculpt Week was just registered with the National Day Calendar organization,
- New Study Highlights Risks of Energy-Based Vaginal Rejuvenationhttps://modernaesthetics.com/news/new-study-highlights-risks-of-energy-based-vaginal-rejuvenation/2471923/Concerns from the federal Food and Drug Administration (FDA) sired the first assessment of adverse events related to device procedures marketed for ‘vaginal rejuvenation,’ and the new analysis of the Manufacturer and User Facility Device Experience (MAUDE) database identified a total
- BTL News: New Small Emsculpt Applicator Targets Arms, Thighs, Calveshttps://modernaesthetics.com/news/btl-news-new-small-emsculpt-applicator-targets-arms-thighs-calves/2471930/BTL is rolling out a small Emsculpt applicator to treat arms, thighs and calves at the annual meeting of the American Society for Laser Medicine and Surgery in Denver. Until now, there were only protocols for the abdominals and buttocks. In addition to launching the small applicat
- Cutera Launches excel V+ the Next Generation Laser Platformhttps://modernaesthetics.com/news/cutera-launches-excel-v-the-next-generation-laser-platform/2471949/Cutera, Inc. has launched its excel V+ laser platform, which the company describes as a technological advancement that includes 50 percent more power and treatment speed, optimized delivery systems and parameters for treating vascular lesions and pigmentation concerns. The company says th
- Evolus: Jeuveau FDA Cleared for Aesthetic Injectionhttps://modernaesthetics.com/news/evolus-jeuveau-fda-cleared-for-aesthetic-injection/2471954/The FDA has approved Jeuveau™ (prabotulinumtoxinA-xvfs), the lead product from Evolus, Inc., for the temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adults. It will be available to physicians this sp